Clinical Trial Update: Masitinib in Patients With Mild Alzheimer's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of masitinib for mild Alzheimer's disease has been updated to not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Masitinib (masitinib)

Snippet

Sponsor: AB Science | Conditions: Alzheimer Disease | Phase 3 | Status: NOT_YET_RECRUITING